Bluejay Diagnostics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$72.99 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$66.97K.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$6.02K.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $129.31K.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$171.73K.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$333.88K.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$150.32K.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$926.22K, a 2371.70% decline from fiscal 2022.
- Bluejay Diagnostics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $40.77K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$66.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$72.99K 10-Q · filed 2026-08-12 | $56.32K derived: sum of 3 quarters · filed 2026-08-12 | -$115.41K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$6.02K 10-Q · filed 2026-05-07 | $123.29K derived: sum of 2 quarters · filed 2026-05-07 | -$48.44K derived: sum of 3 quarters · filed 2026-05-07 | -$199.04K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $129.31K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$42.42K derived: sum of 2 quarters · filed 2026-03-06 | -$193.02K derived: sum of 3 quarters · filed 2026-08-12 | -$333.88K 10-K · filed 2026-03-06 |
| 2025-09-30 | -$171.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$322.33K derived: sum of 2 quarters · filed 2026-08-12 | -$463.19K 10-Q · filed 2025-11-07 | -$678.19K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$150.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$291.46K 10-Q · filed 2026-08-12 | -$506.47K derived: sum of 3 quarters · filed 2026-08-12 | -$654.51K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$140.86K 10-Q · filed 2026-05-07 | -$355.87K derived: sum of 2 quarters · filed 2026-05-07 | -$503.91K derived: sum of 3 quarters · filed 2026-05-07 | -$332.50K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$215.01K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$363.06K derived: sum of 2 quarters · filed 2026-03-06 | -$191.64K derived: sum of 3 quarters · filed 2026-03-06 | -$150.32K 10-K · filed 2026-03-06 |
| 2024-09-30 | -$148.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $23.37K derived: sum of 2 quarters · filed 2025-11-07 | $64.68K 10-Q · filed 2025-11-07 | -$638.86K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $171.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $212.73K 10-Q · filed 2025-08-07 | -$490.81K derived: sum of 3 quarters · filed 2025-08-07 | -$521.52K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $41.31K 10-Q · filed 2025-05-13 | -$662.23K derived: sum of 2 quarters · filed 2025-05-13 | -$692.93K derived: sum of 3 quarters · filed 2025-05-13 | -$1.33M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$703.54K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$734.25K derived: sum of 2 quarters · filed 2025-03-31 | -$1.37M derived: sum of 3 quarters · filed 2025-03-31 | -$926.22K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$30.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$669.21K derived: sum of 2 quarters · filed 2024-11-07 | -$222.68K 10-Q · filed 2024-11-07 | $783.91K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$638.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$191.97K 10-Q · filed 2024-08-14 | $814.62K derived: sum of 3 quarters · filed 2024-08-14 | $424.37K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $446.53K 10-Q · filed 2024-05-15 | $1.45M derived: sum of 2 quarters · filed 2024-05-15 | $1.06M derived: sum of 3 quarters · filed 2024-05-15 | $797.26K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $616.34K derived: sum of 2 quarters · filed 2024-03-28 | $350.73K derived: sum of 3 quarters · filed 2024-03-28 | $40.77K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$390.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$655.86K derived: sum of 2 quarters · filed 2023-11-09 | -$965.81K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$265.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$575.56K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$309.96K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |